Cytarabine 20 mg / mL Injection 25 mL
Comprehensive product details for sourcing and verification.
| NDC 11 | 61703-0304-36 |
|---|---|
| Product NDC | 61703-0304 |
| Generic Drug Name | Cytarabine |
| Brand Name | Cytarabine |
| Manufacturer | Hospira, Inc. |
| Strength | 20 mg / mL |
| Dosage Form | Injection |
| Drug Type | Intravenous; Subcutaneous |
| Package Quantity | 1 Vial, Multi-Dose |
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (61703-304-36) / 25 mL in 1 VIAL, MULTI-DOSE |
| Active Ingredients | Cytarabine |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Cytarabine 20 mg / mL Injection is tracked under NDC 61703-0304-36 and rolls up into product family 61703-0304. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 1 Vial, Multi-Dose.
- Manufacturer: Hospira, Inc..
- Dosage form: Injection.
- Family size: 1 active presentation.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Drug Shortage Information
This NDC appeared in documented shortage listings in 2015 and 2021, a recurring pattern that suggests elevated future supply risk.
Drug Shortage Index family
View Cytarabine in the Drug Shortage IndexCompare related exact NDC products and family-level shortage context for Cytarabine.This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Cytarabine 20 mg / mL Injection 25 mL, NDC 61703-0304-36, is a Hospira, Inc. 20 mg / mL injection presentation packaged as 1 Vial, Multi-Dose. Historical public shortage information is available for this exact presentation.
NDC search formats
- Canonical NDC 11: 61703-0304-36.
- Digits-only NDC 11: 61703030436.
- Possible 10-digit display format: 61703-304-36 (6170330436).
Helpful product links
- Search by brand name: Cytarabine.
- Exact NDC 11: 61703-0304-36.
- Product family NDC: 61703-0304.
Related shortage research
If your team is researching the broader shortage picture, the family page groups related exact NDC items, brand variations, and family-level shortage context in one place.